NAMSA appoints Berthoux as new CEO

NAMSA announced that it appointed Dr. Christophe Berthoux as its new CEO to take over for former president & CEO John Gorski.

Berthoux most recently served as CEO of Synexus Clinical Research Limited and is also currently acting as operating partner at ArchiMed, a private equity healthcare firm that acquired a majority stake in NAMSA in September 2020.

The transition will be made effective March 22, 2021. Gorski will relinquish day-to-day operations to focus on strategy while serving as vice chair of NAMSA’s board of directors, according to a news release.

“Although my desire is to step down as CEO after fully committing 15 years as its leader, my heart is with NAMSA and I will continue to be involved in a meaningful way,” Gorski said in the release. “Dr. Berthoux possesses the expertise and vision for NAMSA’s future goals, and has the talent and drive to lead us forward. I look forward to working more closely with our Board of Dire…

Read more
  • 0